Analyst picks & changes
Finally, both Stone and Butler cited recent events as evidence of a brightening picture for biotech investments in the coming months.
Butler said that the strong earnings of
and
, BGEN's positive beta
Gathering data...
Finally, both Stone and Butler cited recent events as evidence of a brightening picture for biotech investments in the coming months.
Butler said that the strong earnings of
and
, BGEN's positive beta